2024 annual financial data
Tenaya Therapeutics 2024 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -115.95M USD and net income was -111.13M USD.
Operating cash flow was -90.5M USD.
Get free Tenaya Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -115.95M USD
- Net income
- -111.13M USD
- Operating cash flow
- -90.5M USD